<unk>  is a hepatitis C virus protease inhibitor.<unk>  is a NS3/4A protease inhibitor, thus preventing viral maturation through inhibition of protein synthesis.<unk>  is administered as one capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 or genotype 4 chronic hepatitis C in adult people with compensated liver disease (including cirrhosis), with or without HIV-1 co-infection, who are treatment naive or who have failed previous interferon therapy. Genotype 1 is the most prevalent form of hepatitis C virus (HCV) worldwide.
Simeprevir
Saquinavir
Telaprevir
Fosamprenavir
Glecaprevir
Abacavir
Indinavir
Fostemsavir